ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst.

May 13, 1994

ACCC Annual Meeting Jan. 27-29; Upton To speak

November 4, 1977

NIH Defends NCI Sponsored Travel

December 3, 2010

DeVita Suggest Chop Should Be Expanded, Given Long Term Status, But Only With A “Quid Pro Quo”

March 20, 1981

In Brief: Hayard Of Sloan-Kettering, Leder Of Harvard to Share 1985 Bristol-Myer Award Of $50,000

March 29, 1985

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001